| Withdrawn | BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer NCT00397501 | OHSU Knight Cancer Institute | Phase 1 / Phase 2 |
| Completed | Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB NCT00387374 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Cap NCT00296036 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma NCT00317798 | University of Rochester | Phase 1 |
| Completed | 05-001: Treatment of Acute Lymphoblastic Leukemia in Children NCT00400946 | Dana-Farber Cancer Institute | Phase 3 |
| Terminated | Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant NCT00238173 | OHSU Knight Cancer Institute | Phase 1 |
| Completed | Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cel NCT00077311 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Completed | N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neurob NCT00093353 | New Approaches to Neuroblastoma Therapy Consortium | Phase 1 |
| Completed | Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer NCT00245050 | Case Comprehensive Cancer Center | Phase 3 |
| Terminated | Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral NCT00052884 | Eastern Cooperative Oncology Group | Phase 1 |
| Completed | Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cance NCT00075868 | Radiation Therapy Oncology Group | Phase 3 |
| Completed | Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles NCT00324298 | Queen Mary University of London | Phase 3 |
| Terminated | Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen NCT00074165 | OHSU Knight Cancer Institute | Phase 2 |
| Completed | Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chem NCT00055718 | Herbert Irving Comprehensive Cancer Center | Phase 2 |
| Unknown | Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors NCT00024310 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Terminated | Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Canc NCT00025298 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Withdrawn | Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML NCT00003407 | Rush University Medical Center | Phase 2 |
| Completed | Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With NCT00028964 | University of California, San Francisco | Phase 1 / Phase 2 |
| Completed | Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Adv NCT00024427 | Wellstat Therapeutics | Phase 3 |
| Completed | Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer NCT00006012 | Alliance for Clinical Trials in Oncology | Phase 1 / Phase 2 |
| Completed | Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Ca NCT00006105 | University of Chicago | Phase 2 |
| Completed | Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors NCT00003811 | Children's Oncology Group | Phase 2 |
| Completed | Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors NCT00005796 | Indiana University | Phase 1 |
| Completed | Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer NCT00004132 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Completed | Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphom NCT00006345 | Ligand Pharmaceuticals | Phase 2 |
| Completed | Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy NCT00003600 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer NCT00004176 | Washington University School of Medicine | Phase 2 |
| Completed | Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer NCT00003313 | Radiation Therapy Oncology Group | Phase 3 |
| Completed | Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanc NCT00003580 | University of Tennessee | Phase 2 |
| Completed | Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors NCT00003269 | Scripps Health | Phase 2 |
| Completed | Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00003268 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 1 |
| Unknown | Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and N NCT00003251 | University of Illinois at Chicago | Phase 1 / Phase 2 |
| Completed | Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy NCT00003252 | Rush North Shore Medical Center | Phase 4 |
| Unknown | Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer NCT00004036 | The Cleveland Clinic | Phase 1 |
| Completed | Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors NCT00003144 | NYU Langone Health | Phase 1 |
| Unknown | Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer NCT00004264 | University of Wisconsin, Madison | Phase 1 / Phase 2 |
| Completed | Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer NCT00003089 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 |
| Completed | High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Ad NCT00003068 | University of Arizona | Phase 2 |
| Unknown | Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limite NCT00003583 | University of Florida | Phase 2 |
| Completed | Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma NCT00002759 | National Cancer Institute (NCI) | Phase 1 |
| Completed | High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malig NCT00002818 | Virginia Commonwealth University | Phase 1 |